Patent ID: 9527811
Filing Date: 2016-12-27
CPC Classification: A61P,C07D

Claim Text:
1. A method for treating a disorder, an impairment or a condition selected from the group consisting of memory impairment, Alzheimer's disease, Parkinson's disease, Huntington's disease, multiple sclerosis and concomitant damage to the nervous system, acute autoimmune encephalomyelitis, pain, malaria, damage to the heart following cardiac ischemias, damage to the kidney following renal ischemias, and tumors and metastases thereof the method comprising administering to a subject in need thereof a compound of formula I: in which R R R R R R R A is C═O, S(═O) or S(═O) Q is a single bond or a moiety Alk′-Z, wherein X is hydrogen or a radical of the formulae C(═O)—O—R Y is CH or a tautomer thereof or a pharmaceutically acceptable salt thereof, wherein the method is for non-prophylactic treatment of the disorder, impairment or condition.